Cargando...
Pharmacometabolomics Reveals a Role for Histidine, Phenylalanine and Threonine in the Development of Paclitaxel-induced Peripheral Neuropathy
PURPOSE: Approximately 25% of breast cancer patients experience treatment delays or discontinuation due to paclitaxel-induced peripheral neuropathy (PN). Currently, there are no predictive biomarkers of PN. Pharmacometabolomics is an informative tool for biomarker discovery of drug toxicity. We cond...
Gardado en:
| Publicado en: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6119501/ https://ncbi.nlm.nih.gov/pubmed/29946863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4862-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|